FosterWaller

Pharmaceutical QA Infrastructure · Permanent Capital

Critical infrastructure operators,built to compound.

FosterWaller is a permanent capital holding company. We acquire quality assurance operators in pharmaceutical and supplement manufacturing — and build them into a platform.

The Thesis

The QA operators running regulated manufacturing are the most overlooked infrastructure in healthcare.

They are profitable, defensible, and deeply undervalued — because they look like consulting firms, not platform companies. With the right ownership structure and the right technology layer, they are neither.

$500K–$5MTarget EBITDA
4 operator typesQA · Validation · Software · Lab
PermanentCapital Structure

Operating Model

Acquire. Centralize. Deploy.

Three steps. Executed in sequence across every acquisition in the pharma QA ecosystem.

01

Acquire

We source and acquire QA operators with proven cash flows, recurring retainer or SaaS revenue, and established client relationships in FDA-regulated manufacturing. Deal structures are seller-friendly — earnouts, seller notes, equity participation where appropriate. No auction processes.

02

Centralize

Back-office consolidation across finance, HR, and administration. A shared quality management system deployed as the operating standard across all acquired entities. Shared regulatory intelligence monitoring FDA guidance, warning letters, and 483 observations. Cross-sell revenue flows naturally from shared clients who need services the platform now provides across multiple acquired firms.

03

Deploy

AI deployed across the entire platform simultaneously. Compliance document intelligence. Automated batch record workflows. Deviation pattern detection. CAPA routing and closure tracking. Predictive quality analytics on QC data. Regulatory monitoring. Applied at platform scale — the ROI is unavailable to any standalone operator.

Acquisition Criteria

What we look for.

Specific enough that you know immediately whether to reach out.

01

Sector

QA consulting, validation services, compliance software, or QC laboratories serving pharmaceutical, supplement, or contract manufacturers in FDA-regulated markets.

02

Scale

$500K–$5M EBITDA. Below the threshold where institutional PE competes. Above the threshold where the operating model is proven and recurring revenue is established.

03

Revenue Profile

Recurring retainer, SaaS subscription, or long-term service agreements. Not purely project-based. Predictable cash flows tied to ongoing regulatory obligations.

04

Ownership

Founder-owned with operational staff in place. We are not turnaround investors. We acquire businesses that work — and make them compound.

05

Customer

Pharmaceutical manufacturers, supplement producers, contract manufacturers, or medical device companies operating under FDA regulatory requirements.

The Team

Operator expertise. Technology infrastructure.

FosterWaller is built on thirty years of pharmaceutical QA domain knowledge and a technology capability purpose-built for regulated-industry operations.

Managing Partner · Quality & Operations

Rick Augustine

30 years in pharmaceutical quality assurance · M.S.

Rick has spent three decades building, managing, and auditing quality systems across pharmaceutical and supplement manufacturing. His career spans GMP compliance, regulatory submissions, validation programs, and QA infrastructure development for manufacturers operating under FDA oversight. He brings the operational knowledge and industry relationships that define FosterWaller's acquisition and integration capability.

Managing Partner · Technology & Capital

Sam Augustine

5 years building regulated-industry technology infrastructure

Sam has built CRM and data systems for financial services firms operating under strict regulatory requirements — environments where audit trails, compliance workflows, and data governance are non-negotiable. He leads FosterWaller's technology strategy, capital structure, and the AI deployment layer that creates platform-level compounding across acquired operators.

Start a Conversation

We partner where QA infrastructure matters.

If you're operating in pharmaceutical or supplement manufacturing QA and considering a transition — we'd like to understand what you've built.